News & Updates

Show Multimedia Only

Wildfire smoke exposure ups risk of heart failure in older adults

03 Jul 2025

Exposure to wildfire smoke for an extended period may increase the risk of heart failure (HF) in older adults, particularly women and socially vulnerable populations, suggests a study.

Wildfire smoke exposure ups risk of heart failure in older adults

03 Jul 2025

White coat hypertension prevalent in people with elevated clinic BP

03 Jul 2025 by

More than half of individuals with elevated clinic blood pressure (BP) attending a primary care clinic in Singapore have either white coat hypertension (WCH) or undiagnosed hypertension, reports a study.

White coat hypertension prevalent in people with elevated clinic BP

03 Jul 2025

Psilocybin eases depression, with minor impact on brain responsiveness

03 Jul 2025

Treatment with psilocybin results in significant improvements in depressive symptoms, and its use only shows a minor effect on brain responsiveness to emotional stimuli.

Psilocybin eases depression, with minor impact on brain responsiveness

03 Jul 2025

Ropeginterferon α-2b extends benefit to another rare blood cancer

03 Jul 2025 by

Topline results of the phase III SURPASS-ET trial show the superior efficacy of ropeginterferon α-2b (ropeg) compared with anagrelide as second-line (2L) treatment for high-risk essential thrombocythaemia (ET), a rare blood cancer that may progress to myelofibrosis or acute myeloid leukaemia.

Ropeginterferon α-2b extends benefit to another rare blood cancer

03 Jul 2025

Utidelone plus bevacizumab shows promise in ERBB2-negative MBC

03 Jul 2025

Combination treatment with utidelone plus bevacizumab has demonstrated therapeutic potential in patients with ERBB2-negative metastatic breast cancer (MBC) and active brain metastases in a single-arm, phase II study conducted in China.

Utidelone plus bevacizumab shows promise in ERBB2-negative MBC

03 Jul 2025

SURPASS-CVOT emulation sees tirzepatide reduce MACE vs dulaglutide in T2D

03 Jul 2025 by

While results from SURPASS-CVOT are not yet in, observational insurance claims data reveal that tirzepatide reduces MACE vs dulaglutide in adults with T2D, as shown in a target trial emulation presented at ADA 2025

SURPASS-CVOT emulation sees tirzepatide reduce MACE vs dulaglutide in T2D

03 Jul 2025

Undernutrition drives up hospitalizations for older Singaporeans

02 Jul 2025 by

New research points to undernutrition as a key factor contributing to increases in emergency department (ED) visits and inpatient admissions among older adults in Singapore.

Undernutrition drives up hospitalizations for older Singaporeans

02 Jul 2025

Short-course antibiotic for paediatric CAP on par with long-course regimen

02 Jul 2025

A short-course antibiotic treatment for children with community-acquired pneumonia (CAP) demonstrates effectiveness similar to the long-course regimen but with fewer serious adverse events (AEs), reports a study.

Short-course antibiotic for paediatric CAP on par with long-course regimen

02 Jul 2025

AMPLITUDE: Niraparib plus AAP improves survival in mCSPC patients with gene mutations

02 Jul 2025 by

The combination of niraparib (NIRA) and abiraterone acetate plus prednisone (AAP) results in significant improvements in radiographic progression-free survival (rPFS) and time to symptomatic progression (TSP) in metastatic castration-sensitive prostate cancer (mCSPC) patients with alterations in homologous recombination repair (HRR) genes, as shown by the results of the phase III AMPLITUDE trial.

AMPLITUDE: Niraparib plus AAP improves survival in mCSPC patients with gene mutations

02 Jul 2025

Ceftazidime-avibactam, ceftolozane-tazobactam safe for use in children

02 Jul 2025

Treatment with either ceftazidime-avibactam (CAZ/AVI) or ceftolozane-tazobactam (C/T) is well tolerated and effective in children infected with Gram-negative pathogens resistant to carbapenems, a recent study has shown.

Ceftazidime-avibactam, ceftolozane-tazobactam safe for use in children

02 Jul 2025

News & Updates

Filter by Specialty:

Specialty:

Wildfire smoke exposure ups risk of heart failure in older adults

Wildfire smoke exposure ups risk of heart failure in older adults

White coat hypertension prevalent in people with elevated clinic BP

White coat hypertension prevalent in people with elevated clinic BP

Psilocybin eases depression, with minor impact on brain responsiveness

Psilocybin eases depression, with minor impact on brain responsiveness

Ropeginterferon α-2b extends benefit to another rare blood cancer

Ropeginterferon α-2b extends benefit to another rare blood cancer

Utidelone plus bevacizumab shows promise in ERBB2-negative MBC

Utidelone plus bevacizumab shows promise in ERBB2-negative MBC

SURPASS-CVOT emulation sees tirzepatide reduce MACE vs dulaglutide in T2D

SURPASS-CVOT emulation sees tirzepatide reduce MACE vs dulaglutide in T2D

Undernutrition drives up hospitalizations for older Singaporeans

Undernutrition drives up hospitalizations for older Singaporeans

Short-course antibiotic for paediatric CAP on par with long-course regimen

Short-course antibiotic for paediatric CAP on par with long-course regimen

AMPLITUDE: Niraparib plus AAP improves survival in mCSPC patients with gene mutations

AMPLITUDE: Niraparib plus AAP improves survival in mCSPC patients with gene mutations

Ceftazidime-avibactam, ceftolozane-tazobactam safe for use in children

Ceftazidime-avibactam, ceftolozane-tazobactam safe for use in children